FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government Farhat Nasim9 Feb 2020 11:00 AM IST The foreign direct investment (FDI) equity inflow in the drugs and pharmaceutical sector stood at Rs 1,842 crore in FY 2018-19, Minister of State...
US offers 30 Billion US dollars more market to domestic pharma cos Medical Dialogues Bureau30 Jan 2020 3:10 PM ISTMumbai : Domestic pharma companies have the potential to grow their revenue from the US by almost five times at around USD 30 billion from USD 6.5...
DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA Farhat Nasim13 Jan 2020 3:44 PM ISTNew Delhi: In a major setback to drugmaker Geltec Private Limited, the Department of Pharmaceuticals (DoP) has junked its review petition against the...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 11:53 AM ISTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 12:44 PM ISTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 9:20 AM ISTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 9:30 AM ISTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 9:33 AM IST"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection Medical Dialogues Bureau11 Nov 2019 9:15 AM ISTThe drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Farhat Nasim10 Nov 2019 10:00 AM ISTNew Delhi: Drug firm, Laurus Labs Ltd. recently said in a filing that the US health regulator has issued two observations after the inspection of its...
